iSpecimen set for best day ever on COVID-19 research contracts

iSpecimen

22/11/2021 14:14

** Shares of iSpecimen Inc  ISPC.O  jump 79% to $8.82
premarket
    ** Set for best day ever if gains hold; co leads pct.
gainers across U.S. exchanges before opening bell
    ** ISPC, which provides an online marketplace for human
biospecimens, says it has been contracted by federal agencies
and pvt researchers to supply specimens for COVID-19 research
 urn:newsml:reuters.com:*:nPn26wms7a
    ** Co says it has also recently supplied hundreds of human
biospecimens to the U.S. military for ongoing COVID-19 research 
    ** Says its specimens include nasal and oral swabs, saliva,
and blood samples, and are being used to research COVID-19
testing, immunity and spread among close contacts 
    ** More than 6 mln shares traded, about 7,500% more than its
25-DMA; one of most actively traded stocks premarket
    ** Up to Friday's close, stock fell 38.5% from its IPO price
of $8/shr in June

 (Reporting by Ruhi Soni in Bengaluru;)
 ((Ruhi.Soni@thomsonreuters.com; Twitter: https://twitter.com/ruhithere;))